Flurazepam ('Dalmane') in the treatment of insomnia in patients with respiratory disorders.
The effects on subjective aspects of sleep of flurazepam 15 mg and amylobarbitone sodium 100 mg were compared in insomniac patients with chest disease. A double-blind technique was used. The results indicate a significant superiority of flurazepam over the other drug.
D000368:Aged; D000654:Amobarbital / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004325:Dreams / Q000187:drug effects; D005479:Flurazepam / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012140:Respiratory Tract Diseases / Q000150:complications*; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D000654:Amobarbital; D005479:Flurazepam